Breast Cancer Treatment Studies
Moving in Frontiers in Genetics, medRxiv, bioRxiv, eLife, Genome Research, Nature Medicine and Nature Reviews Cancer.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 9
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Breast Cancer Treatment Studies
Newest first · last 60 days
High JAK-STAT pathway activity in breast cancer correlates with improved immunotherapy response, especially in triple-negative breast cancer patients, serving as a predictive biomarker.
- Open access
- 1 cites
PPC-positive endometrial cancers are linked to increased stromal/mesenchymal activity and decreased cytotoxic/antigen-presentation transcriptional programs, correlating with poorer outcomes.
- Open access
GDSC2-inferred oxaliplatin resistance in gastric cancer is linked to increased glycolytic and oxidative metabolic programs, with these features showing favorable or neutral prognostic associations.
- Open access
Global 5-year breast cancer survival rates from 2017-2021 ranged from 39.1% in Africa to 88.5% in the Americas, highlighting significant regional disparities.
- Open access
Genomic features controlling ESR1 binding and activity differ between endometrial and breast cancer, with SOX17 uniquely regulating ESR1 in endometrial cancer.
- Open access
Browse JClub
Journals this month
- bioRxiv6131
- medRxiv1703
- PNAS447
- Sci Adv354
- JAMA262
- Environ Res230
- BMJ182
- Environ Pollution165
- Nat Commun161
- Science141
- Nature138
- Lancet128
- Cell Rep120
- NEJM119
- mBio107
- Plant Cell Environ107
- Curr Biol106
- J Exp Bot106
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3
